Aerobic Exercise Protects from Pseudomonas Aeruginosa-Induced Pneumonia in Elderly Mice
Overview
Authors
Affiliations
Background: Pseudomonas aeruginosa (PS) infection results in severe morbidity and mortality, especially in immune-deficient populations. Aerobic exercise (AE) modulates the immune system, but its effects on the outcomes of pulmonary PS infection in elderly mice are unknown.
Methods: BALB/c mice (24 weeks old) were randomized to sedentary, exercise (EX), PS, and PS + EX groups for the acute experimental setting, and PS and PS + EX groups for the chronic setting. Low-intensity AE was performed for 5 weeks, 60 min/day; 24 h after the final AE session, mice were inoculated with 5 × 104 colony-forming units (CFU) of PS, and 24 h and 14 days after PS inoculation, mice were studied.
Results: AE inhibited PS colonization (p < 0.001) and lung inflammation (total cells, neutrophils, lymphocytes [p < 0.01] in bronchoalveolar lavage [BAL]), with significant differences in BAL levels of IL-1β (p < 0.001), IL-6 (p < 0.01), CXCL1 (p < 0.001), and TNF-α (p < 0.001), as well as parenchymal neutrophils (p < 0.001). AE increased BAL levels of IL-10 and parenchymal (p < 0.001) and epithelial (p < 0.001) IL-10 expression, while epithelial (p < 0.001) and parenchymal (p < 0.001) NF-κB expression was decreased. AE diminished pulmonary lipid peroxidation (p < 0.001) and increased glutathione peroxidase (p < 0.01). Pre-incubation of BEAS-2B with IL-10 inhibited PS-induced epithelial cell expression of TNF-α (p < 0.05), CD40 (p < 0.01), and dichlorodihydrofluorescein diacetate (p < 0.05).
Conclusions: AE inhibits PS-induced lung inflammation and bacterial colonization in elderly mice, involving IL-10/NF-κB, and redox signaling.
Razi O, Teixeira A, Tartibian B, Zamani N, Knechtle B Mol Cell Biochem. 2022; 478(7):1533-1559.
PMID: 36411399 PMC: 9684932. DOI: 10.1007/s11010-022-04610-1.
Factors Associated With Lower Respiratory Tract Infection Among Chinese Students Aged 6-14 Years.
Xue M, Wang Q, Zhang Y, Pang B, Yang M, Deng X Front Pediatr. 2022; 10:911591.
PMID: 35783299 PMC: 9243225. DOI: 10.3389/fped.2022.911591.
Bliss J, Lavery J, Underwood W, Chun S, Fickera G, Lee C Cancer Epidemiol Biomarkers Prev. 2022; 31(5):1036-1042.
PMID: 35506245 PMC: 9135110. DOI: 10.1158/1055-9965.EPI-21-1186.
Novel Predictors of Stroke-Associated Pneumonia: A Single Center Analysis.
Li Y, Zhao L, Liu Y, Lu Y, Yao J, Li C Front Neurol. 2022; 13:857420.
PMID: 35432153 PMC: 9007082. DOI: 10.3389/fneur.2022.857420.
Contributing factors common to COVID‑19 and gastrointestinal cancer.
Kostoff R, Briggs M, Kanduc D, Shores D, Kovatsi L, Drakoulis N Oncol Rep. 2021; 47(1).
PMID: 34779496 PMC: 8611322. DOI: 10.3892/or.2021.8227.